Securities Code: 002332 Securities Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-034
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on the First Repurchase of Company Shares
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or major omissions.
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the Fourth (Extraordinary) Meeting of the Ninth Board of Directors on May 14, 2026, and deliberated and approved the "Proposal on the Share Repurchase Plan." It was agreed that the Company plans to use RMB 80,000,000 (inclusive) to RMB 150,000,000 (inclusive) to repurchase part of the Company's issued RMB common shares (A shares) through centralized bidding transactions. The repurchased shares will be used for the Company's equity incentive or employee stock ownership plan. The funds will come from the Company's own funds and self-raised funds. The repurchase price shall not exceed RMB 13.45 per share (inclusive). The implementation period for this share repurchase is within 12 months from the date the Board of Directors approved this share repurchase plan.